0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of Archives of Internal Medicine |

In This Issue of Archives of Internal Medicine FREE

Arch Intern Med. 2010;170(10):848. doi:10.1001/archinternmed.2010.117.
Text Size: A A A
Published online

DIFFERING SYMPTOM PATTERNS IN EARLY PANDEMIC VS SEASONAL INFLUENZA INFECTIONS

As the influenza A(H1N1/2009) pandemic progresses, more data are being accumulated and analyzed to understand the nature and severity of the clinical disease it causes in different populations living in different environments. This study from a Singaporean population living in a tropical environment suggests that the patterns of clinical symptoms caused by this novel virus differ from those of seasonal influenza, with a tendency to infect a younger age group.

See Article

Β-BLOCKERS FOR CHEST PAIN ASSOCIATED WITH RECENT COCAINE USE

With the hypothesis that β-blockers are safe in cocaine-related chest pain, Rangel et al performed a retrospective cohort study of 331 consecutive patients with chest pain and urine toxicologic test results positive for cocaine. Approximately half of the patients received β-blockers in the emergency department. There were no detectable differences in any adverse event recorded, including differences in electrocardiographic changes, troponin levels, length of stay, use of vasopressor agents, intubation, ventricular tachycardia or ventricular fibrillation, or death in those who did and did not receive a β-blocker. An analysis of the national death index revealed no difference in overall mortality in those who received β-blockers over a median 972 days of follow-up.

See Article

TRENDS IN FALL-RELATED HOSPITAL ADMISSIONS IN OLDER PERSONS IN THE NETHERLANDS

A secular trend analysis was performed to examine numbers and incidences of fall-related hospitalizations among older Dutch adults between 1981 and 2008. In the study period, fall-related hospital admissions doubled. The annual age-adjusted incidence continued to rise. However, owing to a reduction in the hospital admission duration, the number of fall-related hospital bed–days decreased. Because of aging societies worldwide, an increasing impact on fall-related health care consumption is to be expected.

See Article

RELATION BETWEEN RENAL FUNCTION AND OUTCOMES IN PATIENTS WITH NON–ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME

The clinical course and outcomes of patients with non–ST-segment elevation acute coronary syndrome (NSTE-ACS) and kidney disease (KD) was assessed in a population of 13 141 patients enrolled in 3 multinational ACS registries. Patients with KD composed 32% of the study population and were shown to have a significantly higher risk for in-hospital and 30-day mortality. Coronary angiography was associated with a significantly lower risk of mortality among patients with KD, but this high-risk population still exhibited high residual mortality rates. The findings from this study demonstrate that, in a real-world setting, patients with KD compose approximately one-third of the NSTE-ACS population and the presence of KD is an independent predictor of mortality despite current coronary intervention procedures.

See Article

Β-BLOCKERS MAY REDUCE MORTALITY AND RISK OF EXACERBATIONS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Physicians avoid prescribing β-blockers in patients with chronic obstructive pulmonary disease (COPD) and concurrent cardiovascular disease because of concerns about adverse pulmonary effects. With an observational cohort study of 2230 patients 45 years and older with an incident or prevalent diagnosis of COPD and a mean (SD) follow-up of 7.2 (2.8) years, Rutten et al showed that β-blockers may reduce the risk of exacerbations (adjusted hazard ratio, 0.71 [95% confidence interval, 0.60-0.83]) and improve survival of patients with COPD (adjusted hazard ratio, 0.68 [95% confidence interval, 0.56 to 0.83]), possibly owing to dual cardiopulmonary protective properties. Subgroup analyses in patients with COPD without overt cardiovascular disease revealed similar results.

Place holder to copy figure label and caption

Cumulative survival of patients with COPD according to β-blocker use.

Graphic Jump Location

See Article

Figures

Place holder to copy figure label and caption

Cumulative survival of patients with COPD according to β-blocker use.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.